9068 Results

Congress Abstract

Predicting radiotherapy resistance using circulating metabolites in poor prognosis OPSCC

Authors:

Claire Paterson1, Alejandro Huerta Uribe2, Lisa Hay3, Aileen Duffton3, Lynsey Devlin3, Martin MacLeod4, Jeff Evans5, Eileen Soulis6, Oliver Maddocks7

1Beatson West of Scotland Cancer Centre, Clinical Oncology, Glasgow, United Kingdom; 2University of Glasgow, Institute of Cancer Sciences, Glasgow, United Kingdom; 3Beatson West of Scotland Cancer Centre, Therapy Radiography, Glasgow, United Kingdom; 4Glasgow Experimental Cancer Medicine Centre, Clinical Research Facility, Glasgow, United Kingdom; 5University of Glasgow, Institute of Cancer Sciences , Glasgow, United Kingdom; 6University of Glasgow, CRUK Clinical Trials Unit, Glasgow, United Kingdom; 7University of Glasgow, Institute of Cancer Sciences, Glasgow, United Kingdom

Show Affiliations

Congress Abstract

Involved-Field Irradiation in Definitive Chemoradiotherapy for Loco-Regional Esophageal Cancer

Authors: ZHAO|, KUAILE(1)[kuaile_z@sina.com];ZHU|, HONGCHENG(1)*;RIVIN DEL CAMPO|, ELEONOR(2);YUN|, CHEN(1);YE|, JINGJUN(3);ZHU|, ZHENGFEI(1);ZHAO|, WEIXIN(1);ZHOU|, JIALIANG(4);WU|, CHAOYANG(4);TANG|, HUARONG(5);MIN|, FAN(1);LI|, LING(1);LIN|, QIN(6);XIA|, YI(7);LI|, JIANCHENG(8);
(1)FUDAN UNIVERSITY SHANGHAI CANCER CENTER, THORACIC RADIATION ONCOLOGY, SHANGHAI, CHINA;(2)TENON UNIVERSITY HOSPITAL- HÔPITAUX UNIVERSITAIRES EST PARISIEN- SORBONNE UNIVERSITY, RADIATION ONCOLOGY, PARIS, FRANCE;(3)JIANGSU CANCER HOSPITAL-THE AFFILIATED CANCER HOSPITAL OF NANJING MEDICAL UNIVERSITY, RADIATION ONCOLOGY, NANJING, CHINA;(4)AFFILIATED HOSPITAL OF JIANGNAN UNIVERSITY, RADIATION ONCOLOGY, WUXI, CHINA;(5)ZHENJIANG FIRST PEOPLE’S HOSPITAL AFFILIATED TO JIANGSU UNIVERSITY, RADIATION ONCOLOGY, ZHENJIANG, CHINA;(6)THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY, RADIATION ONCOLOGY, XIAMEN, CHINA;(7)FUDAN UNIVERSITY SHANGHAI CANCER CENTER MINHANG BRANCH HOSPITAL, RADIATION ONCOLOGY, SHANGHAI, CHINA;(8)FUJIAN CANCER HOSPITAL- FUJIAN MEDICAL UNIVERSITY CANCER HOSPITAL, RADIATION ONCOLOGY, FUZHOU, CHINA;
Show Affiliations

Congress Abstract

APBI with 3D-CRT vs. WBI: cosmetic and toxicity results of the prospective randomised IRMA trial

Authors: MEDURI|, BRUNO(1)*[brunomeduri@gmail.com];BALDISSERA|, ANTONELLA(2);STAM|, MARCEL(3);BLANDINO|, GLADYS(4);BOERSMA|, LIESBETH(5);PARISI|, SALVATORE(6);VALLI|, MARIACARLA(7);KOITER|, EVELINE(8);FRASSINELLI|, LUCA(1);CIABATTI|, SELENA(2);GIACOBAZZI|, PATRIZIA(1);MORGANTI|, ALESSIO G.(9);D'AMICO|, ROBERTO(10);IOTTI|, CINZIA(4);BERTONI|, FILIPPO(11);POORTMANS|, PHILIP M.P.(12);FREZZA|, GIOVANNI P.(2);
(1)AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA, ONCOLOGY DEPARTMENT - RADIATION ONCOLOGY UNIT, MODENA, ITALY;(2)OSPEDALE BELLARIA – AUSL DI BOLOGNA, RADIOTHERAPY UNIT, BOLOGNA, ITALY;(3)RADIOTHERAPIEGROEP, RADIOTHERAPIEGROEP ARNHEM, ARNHEM, THE NETHERLANDS;(4)AUSL-IRCCS DI REGGIO EMILIA, RADIOTHERAPY UNIT, REGGIO EMILIA, ITALY;(5)MAASTRICHT UNIVERSITY MEDICAL CENTRE + MUMC+, DEPARTMENT OF RADIATION ONCOLOGY MAASTRO, MAASTRICHT, THE NETHERLANDS;(6)CASA DEL SOLLIEVO DELLA SOFFERENZA, RADIOTHERAPY UNIT, S. GIOVANNI ROTONDO FOGGIA, ITALY;(7)OSPEDALE REGIONALE BELLINZONA E VALLI, ISTITUTO ONCOLOGICO DELLA SVIZZERA ITALIANA, BELLINZONA, SWITZERLAND;(8)MEDISCH SPECTRUM TWENTE, RADIOTHERAPY UNIT, ENSCHEDE, THE NETHERLANDS;(9)UNIVERSITY OF BOLOGNA, RADIATION ONCOLOGY CENTER-DEPARTMENT OF EXPERIMENTAL- DIAGNOSTIC AND SPECIALTY MEDICINE, BOLOGNA, ITALY;(10)UNIVERSITÀ DI MODENA E REGGIO EMILIA, DEPARTMENT OF MEDICAL STATISTIC, MODENA, ITALY;(11)AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA, EMERITUS CHAIR OF RADIOTHERAPY UNIT, MODENA, ITALY;(12)PARIS SCIENCES ET LETTRES UNIVERSITY, MARIE CURIE PROFESOR, PARIS, FRANCE;
Show Affiliations

Journal Article

Predicting hypoxia status using a combination of contrast-enhanced computed tomography and [18F]-Fluorodeoxyglucose positron emission tomography radiomics features

Authors: Mireia Crispin-Ortuzar, Aditya Apte, Milan Grkovski, Jung Hun Oh, Nancy Y. Lee, Heiko Schöder, John L. Humm, Joseph O. Deasy

Congress Abstract

Geometric and dosimetric evaluation of submandibular gland sparing following gland transfer

Authors: Moiseenko|, Vitali(1)*[vmoiseenko@ucsd.edu];Atwood|, Todd(1);Coffey|, Charles(2);Hua|, Patricia(1);Cornell|, Mariel(1);Sanghvi|, Parag(1);
(1)University of California San Diego, Radiation Medicine and Applied Sciences, La Jolla, USA;(2)University of California San Diego, Head and Neck Surgical Oncology, La Jolla, USA;
Show Affiliations

Congress Abstract

Implication of BRAF mutations in well-differentiated thyroid carcinoma.

Authors: Dominguez Rullan|, Jose Antonio(1)*[jadrullan@gmail.com];Hernanz Lucas|, Raul(2);Vallejo Ocaña|, Carmen(2);Martín Martín|, Margarita(2);Sancho García|, Sonsoles(2);
(1)Hospital Universitario Ramón y Cajal, Radiation Oncology, Boadilla del Monte, Spain;(2)Hospital Universitario Ramón y Cajal, Radiation Oncology, Madrid, Spain;
Show Affiliations

Congress Abstract

Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer

Authors: Schmidt-Hegemann|, Nina-Sophie(1)*[nina-sophie.hegemann@med.uni-muenchen.de];Eze|, Chukwuka(1);Rogowski|, Paul(1);Schaefer|, Christian(1);Li|, Minglun (1);Buchner|, Alexander (2);Fendler|, Wolfgang Peter (3);Bartenstein|, Peter (4);Ganswindt|, Ute (5);Stief|, Christian (2);Belka|, Claus (1);Kretschmer|, Alexander (2);
(1)Department of Radiation Oncology, University Hospital- LMU Munich, München, Germany;(2)Department of Urology, University Hospital- LMU Munich, München, Germany;(3)Department of Nuclear Medicine, University Hospital Essen, Essen, Germany;(4)Department of Nuclear Medicine, University Hospital- LMU Munich, München, Germany;(5)Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria;
Show Affiliations

Congress Abstract

Dose-volume predictors of distal urethral toxicity after PDR brachytherapy for penile carcinoma

Authors: Achkar|, Samir(1,2)*[samir.achkar@hotmail.com];Bourdais|, Remi(1);Sun|, Roger(1);Kumar|, Tamizhanban(1);Kissel|, Manon(1);Felefly|, Tony(1);Ta|, Minh Hanh(1);Pounou Kamga|, Franck Arthur(1);Escande|, Alexandre(1);Deutsch|, Eric(1);Haie-Meder|, Christine(1);Chargari|, Cyrus(1);
(1)Gustave Roussy, Radiation oncology department, Villejuif, France;(2)Hôtel-Dieu de France, Radiation Oncology department, Beirut, Lebanon;
Show Affiliations

Congress Abstract

Local treatment on the outcome of immune-checkpoint inhibitors in metastatic urothelial carcinoma

Authors: Maldonado|, Javier(1)*[xmaldonado@vhebron.net];Morales Barrera|, Rafael(2);Vidal|, Natalia(3);Feltes|, Nicolas(4);Domenech|, Montserrat(5);Puente|, Javier(3);Figols|, Mariona(5);González|, Macarena(2);Lozano|, Fernando(6);López|, Hector(5);Gallardo|, Enrique(7);Moreno|, Diana(1);Suárez|, Cristina(2);Morote|, Juan(6);Carles|, Joan(2);Giralt|, Jordi(1);
(1)Hospital Universitario Vall d'Hebron, Radiation Oncology, Barcelona, Spain;(2)Hospital Universitario Vall d'Hebron, Medical Oncology, Barcelona, Spain;(3)Hospital Universitario Puerta de Hierro, Medical Oncology, Madrid, Spain;(4)Hospital de Terrassa, Radiation Oncology, Terrassa, Spain;(5)Althaia_ Hospital Sant Joan de Deu, Medical Oncology, Manresa, Spain;(6)Hospital Universitario Vall d'Hebron, Urology, Barcelona, Spain;(7)Hospital Universitari Parc Taulí, Medical Oncology, Sabadell, Spain;
Show Affiliations

Congress Abstract

Small cell carcinoma of the bladder: Retrospective long-term outcomes of chemoradiation

Authors: OH|, Justin(1)*[justin.oh@bccancer.bc.ca];Eigl|, Bernhard(2);Black|, Peter(3);Sunderland|, Katherin(4);Tyldesley|, Scott(1);
(1)BC Cancer, Radiation Oncology, Vancouver, Canada;(2)BC Cancer, Medical Oncology, Vancouver, Canada;(3)University of British Columbia, Urologic Sciences, Vancouver, Canada;(4)BC Cancer, Population Oncology, Vancouver, Canada;
Show Affiliations
*:*